Sharps Technology reports $269.1 million in assets after SOL accumulation

Sharps Technology Inc. reported total assets of $269.1 million for the year ended December 31, 2025, compared to $7.3 million at the end of 2024, according to a company statement. The medical device sales and distribution company accumulated over 2 million SOL tokens as part of its digital asset treasury strategy.

The company generated approximately $7.0 million in total revenue for fiscal year 2025, with $6.8 million coming from net staking revenue and $204,120 from medical device distribution. Sharps reported that approximately 95% of its SOL holdings are actively staked at a 7% gross annualized yield.

Stockholders' equity increased to $264.4 million from $2.0 million at year-end 2024, while total liabilities decreased to $4.7 million. The company eliminated a $3.8 million notes payable balance that existed at the end of 2024 and reported positive working capital of $14.2 million.

Sharps raised over $430 million in total capital during 2025 through equity offerings and warrant exercises, including cash, digital asset, and stablecoin contributions. The company launched its validator through Coinbase's institutional infrastructure and established partnerships with Crypto.com, BitGo, Jupiter Exchange, The Tie, Bonk, and Pudgy Penguins.

"During the year, we transformed the Company's balance sheet, completed our strategic shift away from unprofitable legacy operating activities, established a treasury position of more than 2 million SOL," said Paul K. Danner, Executive Chairman.

The company phased out legacy manufacturing activities while building its SOL treasury position. Sharps filed its Annual Report on Form 10-K for 2025 with the Securities and Exchange Commission on March 31, 2026.

You May Also Be Interested In

• Akari Therapeutics adds oncology expert Patricia LoRusso to advisory board
• IperionX prices $50M public offering of American depositary shares
• Concorde International gets Nasdaq minimum bid price warning